Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Milos S Simic

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 5, 2024
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programsNishith R Reddy, Hasna Maachi, Yini Xiao, et al.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Science Translational Medicine|April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastomaJoseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Science (New York, N.Y.)|December 5, 2024
Engineering synthetic suppressor T cells that execute locally targeted immunoprotective programsNishith R Reddy, Hasna Maachi, Yini Xiao, et al.
Science (New York, N.Y.)|December 5, 2024
Programming tissue-sensing T cells that deliver therapies to the brainMilos S Simic, Payal B Watchmaker, Sasha Gupta, et al.
Science Translational Medicine|April 29, 2021
SynNotch-CAR T cells overcome challenges of specificity, heterogeneity, and persistence in treating glioblastomaJoseph H Choe, Payal B Watchmaker, Milos S Simic, et al.
Pageof 2